The new Covid variant Eris behind a rise in cases this summer
Concerns over ’flying blind’ as routine testing is no longer freely available and less data is being collected
There has been a slight rise in the number of Covid cases in the UK, with more people being admitted to hospital including those requiring intensive care.
A descendant of Omicron, Eris – or EG.5.1 – was first classified as a variant in the UK on 31 July, but now accounts for one in seven new Covid cases.
It is the second most prevalent variant in the UK after Arcturus, which accounts for 39.4% of cases, according to the UK Health Security Agency (UKHSA)
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
As of 29 July, 789,695 people across the UK had symptomatic Covid, with the highest rates recorded in the South West. With routine testing no longer freely available, the real number could well be higher.
“What worries me most is if we get a repeat of the last winter NHS crisis this winter again, with Covid, flu and RSV all hitting around the same time,” Christina Pagel, professor of operational research at University College London, told The Guardian. “We are definitely flying near blind.”
The US is also witnessing a rise in case numbers, which could signal “the first glimpse of the coronavirus as a post-pandemic, seasonal threat, a permanent fixture of the infectious disease landscape”, said The New York Times.
Why is Covid back?
There are plenty of reasons why Covid could be making a comeback, experts say, with waning immunity among them. Last autumn, people over 50 were urged to have a booster, but uptake in England was not all that high; just 40% for people in their early 50s, and 52% for those in their later 50s, reported The Telegraph.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
On top of that, the unseasonably bad weather this summer might be keeping people indoors in poorly ventilated rooms, rather than being outside in the fresh air. Conversely, in southern parts of the US, dangerously high temperatures have also kept people indoors, says Wired.
“It shows something we all know – that the virus is still lurking and that it is dangerous to be complacent,” Professor Lawrence Young, a virologist at Warwick University, told the The Times.
Scientists have also identified a genetic mutation that is linked to a higher likelihood of avoiding symptoms during infection, according to the science journal Nature. This could make it more likely that the virus is being spread by people who don’t realise they have it.
What is Eris?
A new Covid variant, scientifically known as EG.5.1 and descended from Omicron, has been identified, according to Sky News. The emergence of the new variant, which is spreading quickly, could also help explain the rise. Data suggests it now accounts for 14.6% of cases – making it the second most prevalent in the UK. The most dominant variant is Arcturus XBB.1.16 – another descendant of Omicron – which makes up almost 40% of all cases.
What about elsewhere?
Other countries have seen a rise in Covid cases, particularly Asia, with Singapore, India and Indonesia all reporting an increase in April, according to Bloomberg.
In the US, infections and hospitalisations are also on the rise, with the highest increases in the northeast and south, followed by the west and Midwest. However, most deaths from the virus now occur in adults older than 75 and overall deaths from the virus are at their lowest since the pandemic began.
Yet Covid is likely to remain one of the leading causes of death in the United States for the foreseeable future, Justin Lessler, an epidemiologist at the UNC Gillings School of Global Public Health, told The New York Times. Health services could still struggle with any surge of patients over the autumn and winter. Experts also have a “hazier” view than they have had in previous years, reports Wired, with less data being collected by government organisations.
How worried should we be?
Overall the rise in Covid cases and hospitalisations is very slight, and nowhere near the levels seen at the height of the pandemic. No researchers foresee a return to the worst days of the pandemic, said The New York Times, while the elderly account for the vast majority of the rise in hospital admissions.
Even so Tedros Adhanom Ghebreyesus, director-general of the World Health Organization, has said that people “should not let down their guard”. As ever with Covid, the risk will depend on an individual’s health and age. Those who are generally healthy and have either had the virus before or been vaccinated are unlikely to get seriously ill, while older generations and those with underlying medical health issues might be at higher risk. The seasonal vaccine will be available in the autumn in the UK for those who are eligible due to health conditions or age.
Experts will wait to see what the coming months bring, but for now: “Overall levels of admission still remain extremely low and we are not currently seeing a similar increase in ICU admissions,” said Dr Mary Ramsay, head of immunisation at the UKHSA.
-
The best homes of the year
Feature Featuring a grand turret entrance in New York and built-in glass elevator in Arizona
By The Week Staff Published
-
Nordstrom family, investor to take retail chain private
Speed Read The business will be acquired by members of the family and El Puerto de Liverpool, a Mexican real estate company
By Peter Weber, The Week US Published
-
Biden commutes most federal death sentences
Speed Read The president downgraded the punishment of 37 of 40 prisoners on death row to life in prison without parole
By Peter Weber, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Last updated
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published